Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€53.85

€53.85

-0.090%
-0.05
-0.090%
€69.11
 
15.07.24 / Tradegate WKN: 859034 / Symbol: CVS / Name: CVS Health / Stock / Food & Drug Retailing / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

CVS Health Corp. Stock

With only a change of -€0.050 (-0.090%) the CVS Health Corp. price is nearly unchanged from yesterday.
The stock is one of the favorites of our community with 45 Buy predictions and 1 Sell predictions.
As a result the target price of 69 € shows a positive potential of 28.13% compared to the current price of 53.85 € for CVS Health Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for CVS Health Corp. stock. Negative votes have not been in the majority for any criteria for this stock

CVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.

Pros and Cons of CVS Health Corp. in the next few years

Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of CVS Health Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
CVS Health Corp. -0.090% 2.454% -4.267% -15.330% -24.832% -22.496% 5.692%
Cardinal Health Inc. -0.880% -3.888% -8.118% 3.664% -4.422% 79.022% 104.105%
AmerisourceBergen Corp. 0.120% -1.283% -6.100% 19.703% 10.866% 109.179% 156.026%
McKesson Corp. 0.490% -2.498% -3.666% 45.425% 28.213% 232.165% 319.472%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-31

In general, the financials of CVS Health, a major player in the Food & Drug Retailing industry, appear to be stable and relatively strong. The company has shown a steady growth in total assets and revenues over the past few years. However, it is crucial to dig deeper into the financial statements to identify the underlying strengths and potential areas of concern for the company.

Growth in Total Assets and Revenues: CVS Health's total assets and revenues have experienced positive growth from 2020 to 2022. In 2020, the company's total assets were at €230.71 billion, and total revenues were at €268.71 billion. By 2022, these numbers increased to $228.28 billion and $322.47 billion, respectively. This indicates that CVS is continuously expanding its business operations and generating higher sales.

Increasing Gross Profit: CVS Health's gross profit has also seen consistent growth from €49.05 billion in 2020 to $54.29 billion in 2022. This reveals the company's ability to maintain its cost of revenue and increase overall profitability from its core operations.

Comments

Prediction Buy
Perf. (%) -
Target price 60.000
Change
Ends at 16.07.25

As a long-time CVS Health (CVS) shareholder, I've been closely following the company's developments. While recent news about potential legal issues has caused some concern, I believe the stock still presents a solid investment opportunity. CVS is a well-established healthcare giant with a diversified business model, strong brand recognition, and a history of steady growth. The company's recent acquisition of Aetna has positioned it as a major player in the integrated healthcare market, which I see as a promising long-term growth driver. Additionally, CVS's dividend yield of around 3% provides a nice income stream for investors. Sure, there are always risks and uncertainties, but I think the company's fundamentals and growth prospects outweigh the current headwinds. If you're looking for a healthcare stock with decent upside potential and a reliable dividend, CVS could be worth a closer look. Just remember, do your own research and make the decision that's right for your investment strategy and risk tolerance.
Show more

Prediction Buy
Perf. (%) -0.30%
Target price 60.000
Change
Ends at 15.07.25

CVS Health is a well-diversified healthcare company that has weathered recent market turbulence relatively well. Despite some concerns around potential regulatory scrutiny, the company's fundamentals remain strong. The stock is currently trading at a reasonable valuation, and with its attractive dividend and growth prospects, it could be a worthy addition to a balanced portfolio. While there are always risks involved, CVS Health looks poised to deliver solid returns for patient investors willing to ride out any short-term volatility.
Show more

Prediction Buy
Perf. (%) -0.30%
Target price 60.000
Change
Ends at 15.07.25

Based on the latest news and analyses, CVS Health Corp. is a promising investment option. The company's recent performance, diversified business model, and strategic initiatives suggest potential for growth. While there are some concerns around regulatory scrutiny, the overall outlook appears favorable. As a user, I find the stock's current price of $54.14 an attractive entry point, with a reasonable target price of $60. CVS Health's strong market position, synergies from recent acquisitions, and focus on healthcare services make it a compelling investment opportunity worth considering.
Show more